Inhera™

Inhera is a genetic test that looks for inherited genetic variants linked to an increased risk for cancer. 

About 1 in 10 cancer cases are due to a gene variant that can be passed down through family generations. Inhera can help you and your family to be aware of genetic cancer risks and protect the ones you love the most.

Early awareness

Inhera can detect genetic variants in genes related to an increased risk for cancer, helping you and your provider develop a personalized care plan that can often help reduce your risk or detect cancer at an earlier, more treatable stage. 

Helping your family determine risk

Because the tested gene mutations are inherited, your results can be important in shedding light on risk to family members as well as the patient being tested.

In combination with genetic counseling, genetic testing can help you and your family better understand your cancer risk and help you take the path to most effectively prevent, detect, and treat cancer.

Inhera Family of Tests

• Inhera: BRCA1 and 2
  • Tests for genetic variants in the BRCA1 and BRCA2 genes that are associated with an increased risk of developing breast, ovarian, pancreatic, and prostate cancer. These genetic variants are often associated with a family history of these cancers.
• Inhera: Breast and Gynecological Cancer
  • Tests for genetic variants in 23 genes associated with an increased risk of developing breast, ovarian, and other gynecological cancers. This test also includes the BRCA1 and BRCA2 genes, which are most commonly altered in these cancers, but also screens other genes that have been linked to cancer risk. These genetic variants are often associated with a family history of breast and gynecologic cancers.
• Inhera: Lynch Syndrome 
  • Inhera: Lynch Syndrome tests for genetic variants in five genes that are known to be associated with Lynch syndrome. These alterations have been linked with an increased risk of developing colorectal cancer as well as other cancers during a person's lifetime. 
• Inhera: Colorectal Cancer
  • Tests for genetic variants in 18 genes that are associated with an increased risk of developing colorectal cancer, including the five Lynch Syndrome genes.